Combined Synopsis/Solicitation & Notice of Intent to Sole Source to Tradespace for Subscription
FDA · FDA OFFICE OF ACQ GRANT SVCS
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75F40126Q00438 in this department, oldest first.
- Sep 18, 2026Combined Synopsis/SolicitationOpen
- Sep 22, 2026 · this noticeCombined Synopsis/Solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The Government issued Amendment 1 are to provide an updated Notice of Intent to Sole Source and Combined Synopsis/Solicitation (see attached). As a result, the original Notice of Intent to Sole Source and Combined Synopsis/Solicitation dated 09/18/2026 is removed. The updated Notice of Intent to Sole Source and Combined Synopsis/Solicitation dated 09/21/2026, is now effective. The requirement is for the purchase of subscription-based access to a search engine, including all standard market intelligence, commercialization, and IP analytics features, along with associated training and technical … (show all)
support services.
Recent Agency Awards (Loose Match)
24 award notices on SAM.gov in the last 24 months. Matched by: Same agency (FDA), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (24): middle half $402K to $19.1M, median $2.6M; range $82K to $120.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Please_See_Spreadsheet Silver Spring MD 20993 USA | 3 | $153.2M | Oct 8, 2026 |
| DCT, INCORPORATED | 1 | $52.8M | Sep 15, 2026 |
| TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC | 1 | $50.0M | Sep 16, 2025 |
| NATI-NVE Support Services, LLC | 1 | $49.0M | May 21, 2026 |
| HARVARD PILGRIM HEALTH CARE INC | 1 | $31.7M | Mar 30, 2026 |
| TOXICOLOGIC PATHOLOGY ASSOCIATES INC | 1 | $26.1M | Sep 15, 2025 |
| IHRC, INCORPORATED | 1 | $14.5M | Sep 16, 2026 |
| VITALANT Scottsdale AZ 85258 USA | 1 | $10.0M | Sep 8, 2025 |
| WE PHARMA, INC. | 1 | $4.0M | Sep 11, 2026 |
| THE BIONETICS CORP | 1 | $2.8M | Jul 21, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Oct 8, 2026Please_See_Spreadsheet Silver Spring MD 20993 USA$120.8MFY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory ScienceNo listed company matched (Materiality N/A)
- Sep 24, 2026TRADESPACE INC$82KPlatform Subscription to Support Transfer Program Commercial Assessment LeadsNo listed company matched (Materiality N/A)
- Sep 24, 2026TURBOFIL PACKAGING MACHINES, LLC$454KAutomated Vial Capper Machine and Labeler systemNo listed company matched (Materiality N/A)
- Sep 22, 2026ABIDE INTERNATIONAL, INC.$1.8MBuilding Exterior Repair Project � FDA Pacific Southwest LaboratoryNo listed company matched (Materiality N/A)
- Sep 17, 2026LUSARDI CONSTRUCTION CO. San Marcos CA 92078 USA$779KIRV Exhaust and Vacuum Pump ReplacementNo listed company matched (Materiality N/A)
- Sep 16, 2026IHRC, INCORPORATED$14.5MFDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQNo listed company matched (Materiality N/A)
- Sep 15, 2026DCT, INCORPORATED$52.8MNational Center for Toxicological Research (NCTR) on-site facility Operations and Maintenance (O&M) support servicesNo listed company matched (Materiality N/A)
- Sep 11, 2026WE PHARMA, INC.$4.0MPharmaceutical Products for CDER Research Studies - IDIQNo listed company matched (Materiality N/A)
- Aug 31, 2026GOVERNMENT SCIENTIFIC SOURCE INC$399KDigital Slide Scanner SystemNo listed company matched (Materiality N/A)
- Aug 21, 2026Z-SPEC, INC.$123KPost-Award Public NoticeNo listed company matched (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
- 0 of their lobbyists list a past Food & Drug Administration (FDA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 129 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.